Captrust Financial Advisors Enovis Corp Transaction History

Captrust Financial Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$55.44 - $63.8 $203,132 - $233,763	3,664 New	3,664 $228,000
Q4 2022 Feb 15, 2023	BUY	$44.83 - $57.43 $250,285 - $320,631	5,583 New	5,583 $298,000
Q2 2022 Aug 16, 2022	BUY	$55.0 - $70.47 $9,955 - $12,755	181 Added 7.67%	2,542 $140,000
Q1 2022 May 16, 2022	BUY	$62.07 - $80.84 $146,547 - $190,863	2,361 New	2,361 $94,000

310

60.3M

1.68M

693K

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $2.53B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.